01 /What antimicrobial peptides are
Antimicrobial peptides (AMPs) are short cationic peptides produced by virtually all multicellular organisms as part of innate immune defense. They are typically 12 to 50 amino acids long, carry a net positive charge, fold into amphipathic structures with hydrophobic and hydrophilic faces, and act primarily by disrupting microbial cell membranes.
The family is large. Thousands of natural AMPs have been characterized across plants, insects, amphibians, and mammals. The Apothify library lists the most commonly studied research entries from a few of the major families.
02 /The Apothify antimicrobial entries
LL-37 is the only known human cathelicidin antimicrobial peptide, derived by enzymatic cleavage from the hCAP-18 precursor. It is 37 amino acids long, starts with two leucines (hence the name), and is studied in skin barrier research, innate defense research, and wound recovery research.
Magainin II is a 23 amino acid AMP originally isolated from the skin of the African clawed frog (Xenopus laevis) in the late 1980s. It is one of the classical reference antimicrobial peptides and is studied in membrane disruption research.
PR-39 is a 39 amino acid proline and arginine rich cathelicidin originally isolated from porcine small intestine. It acts on intracellular bacterial targets in addition to membrane disruption, which distinguishes it from purely membrane active AMPs.
03 /How they work mechanistically
The classical mechanism is membrane disruption. The cationic peptide binds the negatively charged outer surface of a microbial membrane through electrostatic attraction, then inserts the hydrophobic face into the lipid bilayer, then forms pores or destabilizes the membrane to the point of lysis.
Different AMPs use different membrane disruption modes. Some form barrel stave pores (peptides line a defined pore). Some form toroidal pores (peptides plus lipid form mixed pores). Some act through carpet mechanism (peptides cover the surface and destabilize bulk membrane). The exact mechanism is peptide and membrane composition specific.
Beyond membrane disruption, some AMPs (PR-39 is an example) cross the membrane and act on intracellular targets including bacterial protein synthesis machinery, DNA, and metabolic enzymes.
04 /Research framing in the Apothify library
All three AMPs in the Apothify library are classified ELEVATED. They are presented as encyclopedia entries only with no cart pathway. The reason is regulatory and scientific.
AMPs as a category attract research interest as alternatives to small molecule antibiotics in antibiotic resistance research. Several have advanced to clinical research stages. The compounds are not approved as pharmaceuticals in the United States, and the research peptide commerce around them sits in a different category from the cosmetic and bioregulator commerce that Apothify does support.
05 /Interaction patterns
The Apothify interaction matrix flags AMP pairings as redundant. LL-37 plus Magainin II, LL-37 plus PR-39, and Magainin II plus PR-39 all carry redundant flags. The shared cationic mechanism means stacking adds no clear research signal.
Cross category combinations (e.g., LL-37 plus a thymic peptide like Thymosin Alpha-1) are not flagged with curated rules; the immune research framing is broader than the specific antimicrobial mechanism.
06 /Why selectivity matters
AMPs prefer microbial membranes over mammalian membranes because microbial membranes are more anionic (more negatively charged headgroups). The selectivity is a matter of degree, not absolute. At high concentrations many AMPs will disrupt mammalian membranes as well, which is the main reason they have been hard to translate into systemic clinical use.
Modifications to enhance selectivity for microbial membranes (and reduce mammalian membrane disruption) are an active research area. The peptides in the Apothify library are the natural or near natural sequences; engineered variants are typically not commercially available as research peptides.
07 /Related areas worth knowing
The defensin family is a separate AMP family with cysteine rich disulfide bonded structures. The Apothify library does not list defensins because they are not commonly sold as research peptides outside specialized supply channels.
Tuftsin is a related immune adjacent peptide (a tetrapeptide cleaved from immunoglobulin G). It is listed in the Apothify library and is sometimes compared with AMPs in phagocyte research contexts.
08 /Where the research goes from here
Active research areas include the role of AMPs in skin and gut microbiome research, AMP based approaches to antibiotic resistance research, engineered AMP variants with improved selectivity, and the relationship between natural AMPs and innate immune cell function (neutrophils, macrophages, epithelial cells).
For primary literature, PubMed searches on the specific peptide names return active publication streams.
